AdaptHealth (NASDAQ:AHCO) Stock Gets Price Target Boost from Leerink Partners

Posted by Brenda Bartman on Nov 7th, 2026

AdaptHealth (NASDAQ:AHCO – Get Free Report) had its price objective upped by research analysts at Leerink Partners from $7.00 to $8.00 in a research note issued to investors on Thursday, Benzinga reports. The brokerage presently has an “outperform” rating on the stock. Leerink Partners‘s target price would suggest a potential upside of 9.14% from the company’s previous close.

AHCO has been the topic of several other reports. Truist Financial cut their price target on shares of AdaptHealth from $14.00 to $9.00 and set a “buy” rating on the stock in a research report on Wednesday, August 5th. UBS Group reduced their price objective on shares of AdaptHealth from $10.00 to $9.00 and set a “buy” rating for the company in a research note on Wednesday. Robert W. Baird decreased their price objective on AdaptHealth from $10.00 to $9.00 and set an “outperform” rating for the company in a report on Thursday, September 17th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of AdaptHealth in a research report on Wednesday, August 19th. Finally, Canaccord Genuity Group set a $10.00 target price on AdaptHealth in a report on Wednesday, August 5th. Seven equities research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $9.43.

Get Our Latest Research Report on AHCO

AdaptHealth Stock Down 1.1%

Shares of AHCO traded down $0.08 during mid-day trading on Thursday, hitting $7.33. 2,287,000 shares of the company’s stock were exchanged, compared to its average volume of 2,164,886. The company has a market cap of $999.37 million, a PE ratio of -2.44 and a beta of 1.36. AdaptHealth has a 52 week low of $5.21 and a 52 week high of $13.43. The company has a 50-day simple moving average of $6.00 and a 200 day simple moving average of $9.07. The company has a debt-to-equity ratio of 1.37, a current ratio of 1.12 and a quick ratio of 0.98.

AdaptHealth (NASDAQ:AHCO – Get Free Report) last announced its quarterly earnings data on Tuesday, November 3rd. The company reported ($1.13) EPS for the quarter, missing analysts’ consensus estimates of ($0.05) by ($1.08). AdaptHealth had a positive return on equity of 3.36% and a negative net margin of 7.07%. The business had revenue of $745.65 million during the quarter, compared to the consensus estimate of $725.87 million. During the same period in the prior year, the firm earned $0.16 EPS. The business’s revenue for the quarter was down 9.1% compared to the same quarter last year.

Institutional Investors Weigh In On AdaptHealth

Several hedge funds have recently bought and sold shares of AHCO. Dimensional Fund Advisors LP increased its position in AdaptHealth by 8.1% during the first quarter. Dimensional Fund Advisors LP now owns 6,920,973 shares of the company’s stock worth $82,353,000 after buying an additional 518,274 shares during the last quarter. Principal Financial Group Inc. lifted its position in shares of AdaptHealth by 25.1% in the first quarter. Principal Financial Group Inc. now owns 2,784,316 shares of the company’s stock valued at $33,133,000 after buying an additional 558,357 shares during the last quarter. Lazard Asset Management LLC boosted its stake in shares of AdaptHealth by 35.0% during the 1st quarter. Lazard Asset Management LLC now owns 1,669,454 shares of the company’s stock worth $19,867,000 after acquiring an additional 432,664 shares during the period. Arrowstreet Capital Limited Partnership boosted its stake in shares of AdaptHealth by 87.7% during the 1st quarter. Arrowstreet Capital Limited Partnership now owns 847,085 shares of the company’s stock worth $10,080,000 after acquiring an additional 395,668 shares during the period. Finally, Empowered Funds LLC boosted its stake in shares of AdaptHealth by 1.4% during the 1st quarter. Empowered Funds LLC now owns 622,904 shares of the company’s stock worth $7,413,000 after acquiring an additional 8,602 shares during the period. 82.67% of the stock is currently owned by institutional investors and hedge funds.

About AdaptHealth

(Get Free Report)

AdaptHealth Corp. (NASDAQ: AHCO) is a provider of home medical equipment, supplies and related healthcare services in the United States. The company helps patients manage chronic conditions and recover from illness or injury outside of traditional healthcare facilities, working with individuals, caregivers, physicians and payers.

Its products and services include respiratory equipment and supplies, oxygen therapy, sleep therapy devices such as continuous positive airway pressure systems, diabetes management products, mobility and accessibility equipment, and other durable medical equipment.